We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$34M
AUM Growth
-$21.4M
Cap. Flow
-$4.74M
Cap. Flow %
-13.95%
Top 10 Hldgs %
85.03%
Holding
24
New
2
Increased
2
Reduced
1
Closed
8

Top Buys

Rank Stock Value
1
ATRS
Antares Pharma, Inc.
ATRS
+$409K
2
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$318K

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$2.77M
2
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
+$1.01M
3
ADMS
Adamas Pharmaceuticals
ADMS
+$957K
4
CLVS
Clovis Oncology, Inc.
CLVS
+$727K

Sector Composition

Rank Sector Weight
1 Healthcare 92.53%
2 Miscellaneous 5.79%
3 Consumer Staples 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
1
GSK
GSK
$101B
$4.7M 13.83%
80,000
– –
GILD icon
2
Gilead Sciences
GILD
$184B
$4.55M 13.39%
70,000
– –
ABBV icon
3
AbbVie
ABBV
$456B
$4.43M 13.03%
50,000
– –
CVS icon
4
CVS Health
CVS
$119B
$3.71M 10.94%
50,000
– –
TYME
5
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$3.04M 8.96%
2,175,000
– –
VKTX icon
6
Viking Therapeutics
VKTX
$3.95B
$2M 5.9%
250,000
– –
CAH icon
7
Cardinal Health
CAH
$54.7B
$1.77M 5.21%
35,000
– –
COR icon
8
Cencora
COR
$61.5B
$1.7M 5%
20,000
– –
CLVS
9
DELISTED
Clovis Oncology, Inc.
CLVS
$1.56M 4.6%
150,000
-100,000
-40% -$727K
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
$1.41M 4.15%
300,000
+100,000
+50% +$409K
MCK icon
11
McKesson
MCK
$104B
$1.38M 4.07%
10,000
– –
FOMX
12
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.17M 3.43%
350,000
+100,000
+40% +$318K
CLVS
13
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$1.04M 3.07%
+100,000
New +$727K
ADMS
14
CALL
DELISTED
Adamas Pharmaceuticals
ADMS
$758K 2.23%
+200,000
New +$957K
GNLN icon
15
Greenlane Holdings
GNLN
$1.98M
– –
0
– –
FOMX
16
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$167K 0.49%
50,000
– –
GILD icon
17
CALL
Gilead Sciences
GILD
$184B
– –
-50,000
Closed -$3.17M
SPY icon
18
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$826B
– –
-50,000
Closed -$14.8M
VIXY icon
19
CALL
ProShares VIX Short-Term Futures ETF
VIXY
$214M
– –
-2,500
Closed -$3.9M
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
– –
-50,000
Closed -$2.77M
TYME
21
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
– –
-100,000
Closed -$119K
ATRS
22
CALL
DELISTED
Antares Pharma, Inc.
ATRS
– –
-200,000
Closed -$669K
ADMS
23
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-200,000
Closed -$957K
NVLN
24
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
– –
-1,400,000
Closed -$1.01M

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Healthcare Value Capital held 24 positions worth $34M, down 39% from $55.4M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Healthcare Value Capital withdrew a net $4.74M in Q4 2019, closing 8 positions and reducing 1 holding. Its most notable exit was Walgreens Boots Alliance, an estimated $2.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 58% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Healthcare Value Capital added an estimated $409K to Antares Pharma, Inc..

  • Healthcare Value Capital added most to Antares Pharma, Inc. in Q4 2019, an estimated $409K increase.
  • Healthcare Value Capital's biggest Q4 2019 reduction was Clovis Oncology, Inc., cutting an estimated $727K.
  • Healthcare Value Capital fully exited Walgreens Boots Alliance in Q4 2019, selling an estimated $2.77M.
  • Healthcare Value Capital's ten largest holdings make up 85% of its $34M portfolio in Q4 2019.
  • Healthcare Value Capital opened 2 new positions and closed 8 in Q4 2019.
  • Healthcare Value Capital's portfolio value fell 39% quarter-over-quarter to $34M.

Based on Healthcare Value Capital's 13F filing for Q4 2019, filed 14 Feb 2020.